Causes of adult splanchnic vein thrombosis in the Mediterranean area

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 3, Issue 1, 2011, Pages

  De Stefano, Valerio ^a   Za, Tommaso ^a   Ciminello, Angela ^a   Betti, Silvia ^a   Rossi, Elena ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865990106     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2011.063     Document Type: Article

References (42)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC;European Group for the Study of Vascular Disorders of the Liver. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003; 38: 364-71. http://dx.doi.org/10.1016/S0168-8278(02)00434-8
2. Sarin SK, Sollano JD, Chawla YK, Amarapurkar D, Hamid S, Hashizume M, Jafri W, Kumar A, Kudo M, Lesmana LA, Sharma BC, Shiha G, Janaka de Silva H; Members of the APASL Working Party on Portal Hypertension. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006; 26:512-9. http://dx.doi.org/10.1111/j.1478-3231.2006.01269.x PMid: 16761994
3. Valla D. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 2004; 19: 204-11. http://dx.doi.org/10.1111/j. 1440-1746.2004.03642.x
4. Almdal TP, Sorensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 1991; 13: 650-5. http://dx.doi.org/10.1002/hep.1840130407 PMid:2010159
5. Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival-an 18-year experience. Liver Int 2009;29:253-9. http://dx.doi.org/10.1111/j.1478-3231.2008.01838.x PMid: 18694401
6. Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12: 2115-9. PMid:16610067
7. Acosta S, Alhadad A, Svensson P. Ekberg O. Epidemiology, risk and prognostic factors in mesenteric venous thrombosis. Br J Surg 2008;95:1245-51. http://dx.doi.org/10.1002/bjs.6319 PMid: 18720461
8. Acosta S, Ogren M, Sternby NH, Bergqvist D, Björck M. Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study. J Vasc Surg 2005;41: 59-63. http://dx.doi.org/10.1016/j.jvs.2004.10.011 PMid: 15696045
9. Dentali F, Ageno W, Witt D, Malato A, Clark N, Garcia D, McCool K, Siragusa S, Dyke S, Crowther M; WARPED consortium. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. Thromb Haemost 2009;102:501-4. PMid: 19718470
10. Darvish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, Hansen BE, Rosendaal FR, Janssen HL. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39:500-8. http://dx.doi.org/10.1002/hep.20064 PMid: 14768004
11. Senzolo M, Cholongitas EC, Patch D, Burroughs AK. Update on the classification, assessment of prognosis and therapy of Budd- Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2005;2:182-90. http://dx.doi.org/10.1038/ncpgasthep0143
12. Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, Benhamou JP. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994;106:1042-7. PMid:8143970
13. Darvish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL; EN-Vie (European Network for Vascular Disorders of the Liver). Etiology, management, and outcome of the Budd- Chiari syndrome. Ann Intern Med 2009;151: 167-75. PMid:19652186
14. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, Boudet MJ, Hay JM, Erlinger S, Benhamou JP, Belghiti J, Valla D. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30:84-9. http://dx.doi.org/10.1002/hep.510300125 PMid: 10385643
15. Condat B, Valla D. Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol 2006;3:505-15. http://dx.doi.org/10.1038/ncpgasthep0577
16. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000;32:466-70. http://dx.doi.org/10.1053/jhep.2000.16597 PMid: 10960436
17. Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001;49:720-4. http://dx.doi.org/10.1136/gut.49.5.720 PMid: 11600478 PMCid: 1728504
18. Kumar S, Sarr MG, Kamath PS. Mesenteric vein thrombosis. N Engl J Med 2001;345: 1683-8. http://dx.doi.org/10.1056/NEJMra010076PMid:11759648
19. Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O'Grady J, Praseedom RK, Burroughs AK, Le Treut YP, Kirkegaard P, Rogiers X, Ericzon BG, Hockerstedt K, Adam R, Klempnauer J. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006;44:520-8. http://dx.doi.org/10.1016/j.jhep.2005.12.002 PMid: 16427719
20. Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-91. http://dx.doi.org/10.1002/hep.510310307 PMid: 10706547
21. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-8. PMid:11001884
22. Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell'Era A, Bucciarelli P, Mannucci PM. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006;44:1528-34. http://dx.doi.org/10.1002/hep.21435 PMid:17133457
23. Plessier A, Darwish Murad S, Hernandez Guerra M, et al.; European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2009;51:210-8. http://dx.doi.org/10.1002/hep.23259PMid:19821530
24. Eapen CE, Mammen T, Moses V, Shyamkumar NK. Changing profile of Budd Chiari syndrome in India. Indian J Gastroenterol 2007;26:77-81. PMid:17558071
25. De Stefano V, Teofili L, Leone G, Michiels JJ. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997;23: 411-8. http://dx.doi.org/10.1055/s-2007-996117 PMid:9387199
26. Dahabreh IJ, Zoi K, Giannouli S, Zoi C, Loukopoulos D, Voulgarelis M. Is JAK2 V617F mutation more than a diagnostic index ? A meta-analysis of clinical outcomes in essential thrombocythemia. Leuk Res 2009;33:67-73. http://dx.doi.org/10.1016/j.leukres.2008.06.006PMid:18632151
27. Fiorini A, Chiusolo P, Rossi E, Za T, De Ritis DG, Ciminello A, Leone G, De Stefano V. Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms. Am J Hematol 2009;84:126-7. http://dx.doi.org/10.1002/ajh.21335PMid:19105231
28. Dentali F, Squizzato A, Brivio L, Appio L, Campiotti L, Crowther M, Grandi AM, Ageno W. JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood 2009;113:5617-23 http://dx.doi.org/10.1182/blood-2008-12-196014 PMid: 19273837
29. Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell'Era A, Mannucci PM. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol 2009;50:916-22. http://dx.doi.org/10.1016/j.jhep.2008.12.020 PMid: 19304336
30. Dentali F, Galli M, Gianni M, Ageno W. Inherited thrombophilic abnormalities and risk of portal vein thrombosis. A metaanalysis. Thromb Haemost 2008;99:675-82. PMid: 18392325
31. Ziakas PD, Poulou LS, Rokas GI, Bartzoudis D, Voulgarelis M. Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 2007;5:642-5. http://dx.doi.org/10.1111/j.1538-7836.2007.02379.x PMid:17319910
32. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd- Chiari syndrome: a common complication of Behçet's disease. Am J Gastroenterol 1997:92:858-62. PMid:9149201
33. Rautou PE, Plessier A, Bernuau J, Denninger MH, Moucari R, Valla D. Pregnancy: a risk factor for Budd-Chiari syndrome? Gut 2009; 58: 606-8. http://dx.doi.org/10.1136/gut.2008.167577 PMid:19299391
34. Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou JP. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology 1986;90: 807-11. PMid:3949113
35. Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, Krespis E, Katsaragakis S, Bramis J. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 2006;141:663-9. http://dx.doi.org/10.1001/archsurg. 141.7.663 PMid: 16847237
36. Ghanem J, Hershko C. Veno-occlusive disease and primary hepatic vein thrombosis in Israeli Arabs. Isr J Med Sci 1981;17:339-47. PMid:7263190
37. Hirshberg B, Shouval D, Fibach E, Friedman G, Ben-Yehuda D. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol 2000;32:574-8. http://dx.doi.org/10.1016/S0168-8278(00)80218-4
38. Al Himali SH, Al Osaimi AM, Dahab ST, Khuroo MS, Al Ashgar HI. Budd Chiari syndrome: experience at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Saudi J Gastroenterol 2003;9:11-4. PMid:19861804
39. Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol 2008; 14:2858-62. http://dx.doi.org/10.3748/wjg.14.2858 PMid:18473410 PMCid: 2710727
40. Sakr M, Barakat E, Abdelhakam S, Dabbous H, Yousuf S, Shaker M, Eldorry A. Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study. World J Gastroenterol 2011;17:4704-10. http://dx.doi.org/10.3748/wjg.v17.i42.4704
41. Jadaon MM. Epidemiology of activated protein C resistance and Factor V Leiden mutation in the Mediterranean Region. Mediterr. JHematol Infect Dis 2011, 3(1): e201105 Epub 2011 Nov 28.
42. Ertuğrul I, Köklü S, Başar O, Yüksel O, Uçar E, Coban S, Ibiş M, Arhan M, Odemiş B, Saşmaz N. Thrombosis of the portal venous system: a prospective study. J Clin Gastroenterol 2008; 42:835-8. PMid:18469722